Reuters logo
BRIEF-U.S. district court invalidates four Acorda Therapeutics Ampyra patents
March 31, 2017 / 4:38 PM / 8 months ago

BRIEF-U.S. district court invalidates four Acorda Therapeutics Ampyra patents

March 31 (Reuters) - Acorda Therapeutics Inc:

* U.S. district court issues decision to invalidate four Ampyra patents; company will appeal ruling

* Company has developed contingency plans to address its business needs and objectives in event of a loss of Ampyra exclusivity Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below